1. Home
  2. RVLV vs CRNX Comparison

RVLV vs CRNX Comparison

Compare RVLV & CRNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVLV
  • CRNX
  • Stock Information
  • Founded
  • RVLV 2003
  • CRNX 2008
  • Country
  • RVLV United States
  • CRNX United States
  • Employees
  • RVLV N/A
  • CRNX N/A
  • Industry
  • RVLV Catalog/Specialty Distribution
  • CRNX Biotechnology: Pharmaceutical Preparations
  • Sector
  • RVLV Consumer Discretionary
  • CRNX Health Care
  • Exchange
  • RVLV Nasdaq
  • CRNX Nasdaq
  • Market Cap
  • RVLV 1.4B
  • CRNX 2.8B
  • IPO Year
  • RVLV 2019
  • CRNX 2018
  • Fundamental
  • Price
  • RVLV $22.37
  • CRNX $34.00
  • Analyst Decision
  • RVLV Buy
  • CRNX Strong Buy
  • Analyst Count
  • RVLV 14
  • CRNX 7
  • Target Price
  • RVLV $26.79
  • CRNX $74.33
  • AVG Volume (30 Days)
  • RVLV 1.0M
  • CRNX 1.1M
  • Earning Date
  • RVLV 11-04-2025
  • CRNX 11-11-2025
  • Dividend Yield
  • RVLV N/A
  • CRNX N/A
  • EPS Growth
  • RVLV 38.54
  • CRNX N/A
  • EPS
  • RVLV 0.63
  • CRNX N/A
  • Revenue
  • RVLV $1,182,554,000.00
  • CRNX $1,392,000.00
  • Revenue This Year
  • RVLV $9.12
  • CRNX $489.51
  • Revenue Next Year
  • RVLV $6.65
  • CRNX $661.93
  • P/E Ratio
  • RVLV $35.24
  • CRNX N/A
  • Revenue Growth
  • RVLV 10.68
  • CRNX 0.51
  • 52 Week Low
  • RVLV $16.80
  • CRNX $24.10
  • 52 Week High
  • RVLV $39.58
  • CRNX $62.53
  • Technical
  • Relative Strength Index (RSI)
  • RVLV 50.59
  • CRNX 57.57
  • Support Level
  • RVLV $23.03
  • CRNX $33.19
  • Resistance Level
  • RVLV $24.29
  • CRNX $37.23
  • Average True Range (ATR)
  • RVLV 0.79
  • CRNX 1.49
  • MACD
  • RVLV 0.04
  • CRNX 0.23
  • Stochastic Oscillator
  • RVLV 36.90
  • CRNX 55.87

About RVLV Revolve Group Inc.

Revolve Group Inc is an emerging e-commerce retailer, selling women's dresses, handbags, shoes, beauty products, and incidentals across its marketplace properties, Revolve and FWRD. The platform is built to suit the "next-generation customer," emphasizing mobile commerce, influencer marketing, and occupying an aspirational but attainable luxury niche. With $1.1 billion in 2024 net sales, the firm sits just outside the top 30 apparel retailers (by sales) in the U.S, but has consistently generated robust top-line growth as the industry continues to favor digital channels. Revolve generates approximately 18% of sales from private-label offerings, while focusing on building an inventory of distinctive products from emerging fashion brands with less than $10 million in annual sales.

About CRNX Crinetics Pharmaceuticals Inc.

Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.

Share on Social Networks: